8 HR carbidopa 61.25 MG / levodopa 245 MG Extended Release Oral Capsule [Rytary]
RxNorm concept 1600917, branded drug (sbd). Prescribable name: RYTARY 61.25 MG / 245 MG 8HR Extended Release Oral Capsule.
- RxCUI
- 1600917
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1600917 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
8 HR Carbidopa 61.25 MG / L-DOPA 245 MG Extended Release Oral Capsule [Rytary]; Rytary (carbidopa 61.25 MG / levodopa 245 MG) 8 HR Extended Release Oral Capsule
Related concepts
- carbidopa 61.25 MG (SCDC, consists of)
- levodopa 245 MG (SCDC, consists of)
- carbidopa 61.25 MG / levodopa 245 MG [Rytary] (SBDC, consists of)
- Extended Release Oral Capsule (DF, has dose form)
- Rytary (BN, has ingredient)
- 8 HR carbidopa 61.25 MG / levodopa 245 MG Extended Release Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1600917 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1600917 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1600917. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.